Table 1 Baseline characteristics of trial participants, by treatment group
ASAQ | AL | ||
|---|---|---|---|
Patients included | 156 | 145 | - |
Age (months) | 27.6 (6–59; 14.3) | 27.4 (6–59; 15.0) | |
Sex (female) | 83 (53.3%) | 69 (47.6%) | |
Weight (kg) | 10.3 (5.1-17.0; 2.7) | 10.2 (5.3-16.0; 2.6) | |
Axillary temperature (°C) | 37.6 (34–40.5; 1.3) | 37.6 (35.2-40.0; 1.1) | |
Patients with fever (T° ≥ 37.5°C) | 79 (50.6%) | 71 (48.9%) | |
Haemoglobinaemia (g/dL) | 9.0 (4.0-13.3; 1.9) | 9.0 (5.3-15.5; 2.1) | |
Anaemia 5- < 8 g/dl | 50 (32.0%) | 51 (35.2%) | |
8-11 g/dl | 83 (53.2%) | 65 (44.8%) | |
> 11 g/dl | 23 (14.8%) | 29 (20.0%) | - |
Geometric mean parasite density (/μL) (IQR) | 17111 (34674) | 14886 (53420) | |
Proportion ≥ 100,000 para/μL | 13 (8.3%) | 11 (7.5%) | |
Patients with gametocytes | 9 (5.8%) | 7 (4.8%) |